314
Views
23
CrossRef citations to date
0
Altmetric
Letter

Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia

, , , , , & show all
Pages 643-645 | Received 05 May 2012, Accepted 24 Jul 2012, Published online: 02 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

R. Scotto, A. Reia, A.R. Buonomo, M. Moccia, G. Viceconte, E. Pisano, E. Zappulo, V. Brescia Morra & I. Gentile. (2021) Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review. Expert Opinion on Drug Safety 20:8, pages 925-936.
Read now
Aref Shariati, Alireza Moradabadi, Zahra Chegini, Amin Khoshbayan & Mojtaba Didehdar. (2020) An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies. Infection and Drug Resistance 13, pages 2329-2354.
Read now
Maria V. Dioverti, Sameer A. Parikh, Douglas R. Osmon, Thomas M. Habermann & Aaron J. Tande. (2019) Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms. Leukemia & Lymphoma 60:4, pages 920-926.
Read now
Monica A. Slavin & Sharon C.-A. Chen. (2013) Cryptococcosis, lymphoproliferative disorders and modern day chemotherapy regimens. Leukemia & Lymphoma 54:3, pages 449-450.
Read now

Articles from other publishers (19)

Katrina M. Jackson, Minna Ding & Kirsten Nielsen. (2023) Importance of Clinical Isolates in Cryptococcus neoformans Research. Journal of Fungi 9:3, pages 364.
Crossref
Xiaofeng Xu, Liping Cao, Yijie Wang, Jia Liu, Qing Dong, Chunling Liang, Ying Jiang & Fuhua Peng. (2022) Clinical profile and outcome of non-HIV-infected patients with cryptococcal meningitis and malignancy. Journal of Medical Mycology 32:3, pages 101250.
Crossref
Minna Ding, Kyle D. Smith, Darin L. Wiesner, Judith N. Nielsen, Katrina M. Jackson & Kirsten Nielsen. (2022) Use of Clinical Isolates to Establish Criteria for a Mouse Model of Latent Cryptococcus neoformans Infection. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Michael K. MansourOlivia C. SmibertAvinash KambadakoneMaroun M. Sfeir. (2020) Case 31-2020: A 48-Year-Old Man with Lymphoma and Abdominal Pain. New England Journal of Medicine 383:15, pages 1469-1477.
Crossref
Samuel Okurut, David R. Boulware, Joseph Olobo & David B. Meya. (2020) Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection . Mycoses 63:8, pages 840-853.
Crossref
Imran Mohamedy & Graeme N. Forrest. (2020) Cryptococcal Immune Reconstitution Inflammatory Syndrome: a Paradoxical Response to a Complex Organism. Current Treatment Options in Infectious Diseases 12:1, pages 13-29.
Crossref
Anna Maria Peri, Raffaella Rossio, Francesco Tafuri, Valentina Benzecry, Anna Grancini, Gianluigi Reda, Alessandra Bandera & Flora Peyvandi. (2019) Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia. Annals of Hematology 98:12, pages 2847-2849.
Crossref
Matthew Stankowicz, Megan Banaszynski & Russell Crawford. (2018) Cryptococcal infections in two patients receiving ibrutinib therapy for chronic lymphocytic leukemia. Journal of Oncology Pharmacy Practice 25:3, pages 710-714.
Crossref
Adam Suleman, Ruth Padmore, Carolyn Faught & Juthaporn Cowan. (2019) Disseminated cryptococcal infection in a patient with treatment-naïve chronic lymphocytic leukemia (CLL). IDCases 17, pages e00566.
Crossref
Mariana Guarana, Jose Ernesto Vidal & Marcio Nucci. (2018) Cryptococcosis in Patients with Hematologic Diseases. Current Fungal Infection Reports 12:4, pages 187-194.
Crossref
Ioannis Kyriakidis, Athanasios Tragiannidis, Ilse Zündorf & Andreas H. Groll. (2017) Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses 60:8, pages 493-507.
Crossref
Andrew Nixon, Leanne Ogden, Alexander Woywodt & Ajay Dhaygude. (2017) Infectious complications of rituximab therapy in renal disease. Clinical Kidney Journal 10:4, pages 455-460.
Crossref
Livio Pagano, Alessandro Busca, Anna Candoni, Chiara Cattaneo, Simone Cesaro, Rosa Fanci, Gianpaolo Nadali, Leonardo Potenza, Domenico Russo, Mario Tumbarello, Annamaria Nosari, Franco Aversa, Federica Lessi, Marianna Criscuolo, Francesca Farina, Maria Chiara Tisi, Gloria Turri, Angelica Barone, Angelica Spolzino, Maria Ilaria Del Principe, Angela Maria Quinto, Roberta Di Blasi, Laura Maracci, Mitja Nabergoj, Benedetta Cambò, Anna Pegoraro, Francesco Marchesi, Silvia Pascale, Angela Passi, Melania Carlisi, Nicola Polverelli, Barbara Beggia, Benedetta Rambaldi, Lucia Prezioso & Marco Sanna. (2017) Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. Blood Reviews 31:2, pages 17-29.
Crossref
Julia A. Messina, Eileen K. Maziarz, Andrej Spec, Dimitrios P. Kontoyiannis & John R. Perfect. (2017) Disseminated Cryptococcosis With Brain Involvement in Patients With Chronic Lymphoid Malignancies on Ibrutinib. Open Forum Infectious Diseases 4:1.
Crossref
Sarah A. Schmalzle, Ulrike K. Buchwald, Bruce L. Gilliam & David J. Riedel. (2016) Cryptococcus neoformans infection in malignancy . Mycoses 59:9, pages 542-552.
Crossref
Koh Okamoto, Laurie A. Proia & Patricia L. Demarais. (2016) Disseminated Cryptococcal Disease in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib. Case Reports in Infectious Diseases 2016, pages 1-3.
Crossref
Nathan D. Gundacker & John W. Baddley. (2015) Fungal Infections in the Era of Biologic Therapies. Current Clinical Microbiology Reports 2:2, pages 76-83.
Crossref
Kenneth V. I. Rolston. 2015. Infections in Hematology. Infections in Hematology 25 37 .
. (2013) Cyclophosphamide/fludarabine/rituximab. Reactions Weekly 1447:1, pages 16-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.